AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology

November 7, 2019 sandiegobiotech News Comments Off on AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
/

SAN DIEGO–(BUSINESS WIRE)–AvantGen Announces Strategic Collaboration to Develop NK Cell Engager Technology